Episode 8:
Outsmarting Opioids

BY MATT BARRERA & BLANTON GILLESPIE

What types of treatments are available for opioid addiction and overdose? And, can chemists find a way to outsmart opioids to save lives? Tune in and dive into a neuropharmacological action adventure story!

This episode was produced as part of an upper level course on Neuropharmacology taught by Angel Kaur during Fall 2018 at UNC Asheville.

Club Kaur
8. Outsmarting Opioids
/

Articles Referenced

  • Lofwall, M. R, Walsh S. L, Nunes E. V.; JAMA Intern Med. , 2018, 178(6), 764-773. 
  • Nasser, A. F.; Greenwald, M. K.; Vince, B.; Fudala, P. J.; Twumasi-Ankrah, P.; Liu, Y.; Jones, J.; Heidbreder, C. Journal of Clinical Psychopharmacology, 2016, 36(1), 18-26.
  • Bickel, W. K.; Stitzer, M. L.; Bigelow, G. E.; Liebson, I. A.; Jasinski, D. R.; Johnson, R. E. Clinical Pharmacology and Therapeutics 1988, 43 (1), 72–78.
  • Bickel, W. K.; Stitzer, M. L.; Bigelow, G. E.; Liebson, I. A.; Jasinski, D. R.; Johnson, R. E. The J. of Pharm. and Experimental Therapeutics 1988, 247 (1), 47–53.
  • Campbell, N. D.; Lovell, A. M. Annals of the New York Academy of Sciences 2012, 1248 (1), 124–139.
  • Heel, R.; Brogden, R.; Speight, T.; Avery, G. Drugs 1979, 17 (2), 81–110.
  • Jacob, J.; Michaud, G.; Tremblay, E. British Journal of Clinical Pharmacology 1979, 7 (S3), 291–296.
  • Jasinski, D. R. Archives of General Psychiatry 1978, 35 (4), 501–516.
  • Jasinski, D. British Journal of Clinical Pharmacology 1979, 7 (S3), 287–290.
  • Johnson, R. E. Journal of the American Medical Association 1992, 267 (20), 2750–2755.
  • Kim, H. K.; Nelson, L. S. Expert Opinion on Drug Safety 2015, 14 (7), 1137–1146.
  • Mintzer, I. L.; Eisenberg, M.; Terra, M.; Macvane, C.; Himmelstein, D. U.; Woolhandler, S. The Annals of Family Medicine 2007, 5 (2), 146–150.
  • Rance, M. British Journal of Clinical Pharmacology 1979, 7 (S3), 281-286.

 

 

  • Understanding opioid dependence. https://www.suboxone.com/understanding-opioid-dependence (accessed Sep 19, 2018).
  • Wiegand, T. M. Journal of Medicinal Toxicology 2015. 12(1). 64-70
  • Al-Hasani, R.; Bruchas, M. R. Anesthesiology 2011115 (6), 1363-1381.
  • Galligan, J. J.; Akbarali, H. I. The Am. J. of Gastroenterology Supplements 20142, 17-21.
  • Chahl, L. A. Experimental and Clinical Pharmacology: Opioids – mechanisms of action 1996, 19 (3), 63–65.
  • Chiang, C. N. Pharmacokinetics of the combination tablet of buprenorphine and naloxone 2003, 70(2), 39–47.
  • Dorp, E. V.; Yassen, A.; Sarton, E.; Romberg, R.; Olofsen, E.; Teppema, L.; Danhof, M.; Dahan, A. Naloxone Reversal of Buprenorphine-induced Respiratory Depression 2006, 105 (1), 51–57.
  • Ghelardini, C. The pharmacological basis of opioids 2015, 219–221.
  • Giglio, R. E.; Li, G.; Dimaggio, C. J. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis 2015, 2 (1).
  • Ke, Y.-Y.; Huang, Y.-H.; Chien, W.-C.; Loh, H. H.; Chuang, J.-Y.; Yeh, S.-H. Mapping the naloxone binding sites on the mu-opioid receptor using cell-based photocrosslinkers 2017, 1865 (3), 336–343.
  • Kim, H. K.; Nelson, L. S. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review 2015, 14 (7), 1137–1146.
 

 

Related Reading

Credits

Written, Directed, and Featuring: Blanton Gillespie and Matthew Barrera 
Scientific Research byBlanton Gillespie and Matthew Barrera
Additional Sound EngineeringAngel Kaur

Episode Transcript (forthcoming)

New episodes

Tune in for new episodes every other week on Tuesday at 5am.

Be our guest?